Each week we look for the best blog posts, articles, and commentary on supply chain orchestration, logistics innovation, and industry news to share.
This week we're reading about supply chain visibility in relation to the new EU GDPR law going into effect later this month, pharmaceutical companies and their progress in complying with the U.S. Drug Supply Chain Security Act, how buying online and returning in-store is skewing key brick-and-mortar store metrics and contractual pay-outs for commercial lessors, and the market forces that are preventing grocers and CPG's from raising their prices during this economic boom.
Let's dig in...
Firms Lack Supply Chain Visibility as GDPR Looms - By Cristiano Dalla Bona (@cristiano_db), Supply Management (@supplymgmt) - The General Data Protection Regulation (GDPR) goes into effect on May 25th, but a recent survey of 975 companies around the world by Deloitte found 57% believe they are not able to appropriately monitor the subcontractors employed by third parties in their supply chain. “Compliance with GDPR not only covers organizations themselves, but also the contractors and subcontractors they engage. Under the regulation, subcontractors representing fourth and fifth parties must be appropriately monitored."
Mall Owners, Retailers Clash on Avalanche of Online Returns - By Sarah Mulholland (@SMulholland_), Bloomberg (@business) - A new issue for mall owners to contend with: retailers deducting returns for items bought online from their sales figures. David Simon, chief executive officer of Simon Property Group Inc., says a “significant number” of tenants are underreporting sales and that the company, the largest U.S. mall owner, is negotiating with them to find a solution.
Supply Chain Technology: It’s Not Just for Big Businesses Anymore, but is it Enough? - By Jon Slangerup, American Global Logistics via Supply Chain Management Review - A well-written by-line with advice for SMBs on selecting the right technology for supply chain visibility and control. We couldn't agree more with the two main factors Jon stresses for any vendor selected: ability to customize and deep domain expertise. Cloud figures into this as a great equalizer in providing fast, flexible, cost-effective solutions for agile SMBs as well.
The Drug Supply Chain Security Act: A Progress Report - By Edwin Lopez, (@EdwinLopezT37), Supply Chain Dive (SupplyChainDive) - It's five years into the 10 year implementation period the FDA is giving pharmaceutical companies to comply with the Drug Supply Chain Security Act (DSCSA). "The DSCSA is more than a rule, it's a global mandate, requiring any company wishing to sell a pharmaceutical product in the U.S. to facilitate product "traceability" by 2023." The drug serialization step, which was supposed to be enforced in 2017, has been extended to November 2018, though it appears that not all companies will have their products completely serialized by then either. Change management and a lack of adequate tools to support the FDA's requirements are cited as two challenges in some real-life implementation stories.
The Economy is Booming, So Why Can’t U.S. Grocers Hike Prices? - By Craig Giammona,(@SitkaWriter) The Seattle Times (@seattletimes) - An interesting look at the forces keeping grocers and consumer goods organizations from being able to successfully raise their prices. The heated competition between Walmart and Amazon and an erosion of consumer brand power that's due, in part, to more private label and upstart brand partnerships happening with these retailer channels are cited. It will be interesting to see how this continues to evolve.
And that's our five favorites for this week. Did we miss any? Let us know by tweeting us @MPObjects.